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ABSTRACT Sphingosine, at 5–15 mol % total lipids, remarkably increases the permeability to aqueous solutes of liposomal and
erythrocyte ghostmembranes. The increasedpermeability cannot be interpreted in termsof leakage occurring at the early stages of a
putative membrane solubilization by sphingosine, nor is it due to a sphingosine-induced generation of nonlamellar structures, or ﬂip-
ﬂop lipid movement. Instead, sphingosine stabilizes (rigidiﬁes) gel domains in membranes, raising their melting temperatures and
increasing the transition cooperativity. Structural defects originating during the lateral phase separation of the ‘‘more rigid’’ and ‘‘less
rigid’’ domains are likely sites for the leakageof aqueous solutes to theextravesicularmedium. Thepresenceof coexisting domains in
the plasma membrane makes it a target for sphingosine permeabilization. The sphingosine-induced increase in rigidity and break-
down of the plasma membrane permeability barrier could be responsible for some of the physiological effects of sphingosine.
INTRODUCTION
Sphingosine ((2S, 3R, 4E)-2-amino-4-octadecen-1,3-diol) is
the most common sphingoid long chain base in sphingolipids.
It is the precursor of important cell signaling molecules, such
as ceramides, through amide binding of a fatty acid to the C2
amino group, and sphingosine-1-phosphate (see review in
Futerman and Hannun (1)). In addition, sphingosine is a
‘‘bioactive lipid’’ itself. It has been found to inhibit protein
kinase C in human platelets (2), to inhibit phosphatidate
phosphohydrolases in rat hepatocytes (3), and to activate
PKH protein kinases in yeast endocytosis (4).
As with most bioactive lipids, sphingosine can, in princi-
ple, exert its effects either through specific binding to an
enzyme, or indirectly, through changes in cell membrane
properties. This dual possibility has been explored in detail for
ceramides (5,6) but not for sphingosine, whose structural
effects on the lipid bilayer have received less attention. Most
of what we know of the biophysical properties of sphingosine
comes from the studies by the groups of Go´mez-Ferna´ndez
(7–10) and Kinnunen (11–15). The former authors observed,
using 31P-NMR, that sphingosine in membranes has an
apparent pKa ¼ 8.9, thus it is positively charged under
physiological conditions (8). The interaction of fully proton-
ated sphingosine (pH 6.0) with dipalmitoylphosphatidylcho-
line (DPPC) and dielaidoylphosphatidylethanolamine (DEPE)
bilayers was described in detail (7) using differential scanning
calorimetry (DSC) and 31P-NMR.
In mixtures with either diacylphosphatidylcholines (7,11,
13) or phosphatidylserine (PS) (8,11), DSC, NMR, and
surface pressure measurements revealed that sphingosine
rigidified the membranes, forming azeotropic mixtures. More-
over, at neutral pH, being positively charged, sphingosine
neutralized the electrostatic charge of PS, and prevented this
phospholipid from binding cations such as Ca21 (9). Be-
cause of its cationic nature at neutral pH, sphingosine has
been used in the preparation of positively charged liposomes
for DNA transfection (12). Previously, Kinnunen et al. had
demonstrated that the association between DNA and sphin-
gosine could be reverted by acidic phospholipids (14).
Sphingosine has also been found to promote binding of the
assembly factor P17 from bacteriophage PRD1 to lipid
bilayers (13). Mustonen et al. (15) showed very intriguing,
apparently electrostatically mediated effects of sphingosine
on the interactions of proteins (phospholipase A2, cyto-
chrome c) with membranes. Furthermore, a recent report (16)
indicates that sphingosine, like ceramide, may increase the
permeability of model and cell membranes. The membrane-
permeabilizing effects of ceramide were first described by
Ruiz-Argu¨ello et al. (17) and later confirmed by further work
by Siskind et al. (16) and by ourselves (18–20).
This report deals with the amphiphillic properties of
sphingosine, particularly its permeabilizing effects in lipid
vesicles and erythrocyte ghosts. These effects are attributed
to a peculiar property of sphingosine when interacting with
certain lipid mixtures, namely the stabilization of high-melting
domains. The concomitant generation of interfaces between
rigid and fluid domains would be at the origin of the observed
increased permeability.
MATERIALS AND METHODS
Materials
Egg phosphatidylcholine (PC) and egg phosphatidylethanolamine were
from Lipid Products (Redhill, UK); cholesterol (Ch) and 2,2,6,6-
tetramethyl-1-piperidinyloxy (TEMPO, free radical) were purchased from
Sigma (St. Louis, MO); egg ceramide, D-erythro-sphingosine, egg sphingo-
myelin (SM), and 1,2-dielaidoyl-sn-glycero-3-phosphocholine (DEPC) were
obtained from Avanti Polar Lipids (Alabaster, AL). 1,6-Diphenyl-1,3,5-
hexatriene (DPH) was from Molecular Probes (Eugene, OR). Ethanol was
obtained from Prolabo (Paris, France).
8-Aminonaphthalene-1,3,6-trisulfonic acid (ANTS) and p-xylenebis
(pyridinium bromide) (DPX) were supplied by Molecular Probes.
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Liposome preparation
Lipids were dissolved in chloroform/methanol, 2:1 (v/v), at the desired molar
ratios. The lipid was deposited as a film on the wall of a glass test tube by
solvent evaporation under nitrogen. Final traces of solvent were removed for
2 h in a vacuum chamber. The lipid film was suspended in the appropriate
HEPES buffer (10 mM HEPES, 200 mM NaCl, 10 mM CaCl2, 2 mM Mgcl2,
pH 7) by vortexing at room temperature to form multilamellar vesicles. To
ensure homogeneous dispersion, the hydrated samples were extruded
between two syringes through a narrow tubing (0.5 mm internal diameter)
100 times at 45C. The lipid suspensions were further processed through
10 cycles of freezing and thawing, followed by 10 passes through two
polycarbonate filters (Nuclepore, Pleasanton, CA), 0.1 mm pore diameter, in
an extruder at room temperature. For assays of vesicle and erythrocyte ghost
efflux, the buffer contained ANTS and DPX (21). Nonencapsulated
fluorescent probes were separated from the vesicle suspension using a
Sephadex G-75 gel filtration column (Pharmacia, Uppsala, Sweden). Solution
osmolarities were measured using an Osmomat 030 instrument (Gonotec,
Berlin, Germany). The resulting vesicles had an average diameter of 120–150
nm, depending on lipid compositions. Liposomes (large unilamellar vesicles
(LUVs)) were kept on ice and used immediately after preparation.
Ghost membrane preparation
Human erythrocyte ghost membranes were obtained by a modified Steck
and Kant method (22). Briefly, the membranes obtained from 20 ml of
erythrocyte concentrate (as provided by the blood bank) were washed three
times by centrifugation in 0.9% NaCl, and the pellet was resuspended in cold
1.3 mM acetic acid, 4 mM MgSO4, pH 3.2, buffer, left for 30 min at 4C,
and centrifuged. In the next step, the pellet was suspended in 3 volumes of
10 mM HEPES, 200 mM NaCl, 10 mM CaCl2, 2 mM MgCl2, 20 mM
ANTS, and 90 mM DPX, pH 7,4. followed by 10 cycles of freezing and
thawing. Finally, the membranes were stabilized and allowed to reseal by
incubating overnight at 37C. The membranes were washed three times by
centrifugation (20 min, 48,0003 g, 4C) in 10 mM HEPES, 200 mM NaCl,
10 mM Cacl2, 2mM MgCl2, pH 7.4 buffer to separate the nonencapsulated
fluorescent probes from the membranes. Finally, the pellet was resuspended
in 2 ml HEPES buffer. The resulting membranes had an average diameter of
300–310 nm, according to quasielastic light scattering measurements
performed with a Zetasizer4 instrument (Malvern Instruments, Malvern,
UK). Membranes from erythrocytes ghosts were kept on ice and used im-
mediately after preparation.
Differential scanning calorimetry
Samples for DSC were prepared by mixing the appropriate lipids in organic
solvent that was later evaporated under nitrogen current. The resulting dry
lipid films were left under vacuum for at least 2 h to remove solvent traces.
The lipids were dispersed in the HEPES buffer at 45C with shaking. Both
lipid suspensions and buffer were degassed before being loaded into the
sample or reference cell of an MC-2 high-sensitivity scanning calorimeter
(MicroCal, Northampton, MA). Three heating scans, and occasionally a
cooling one, at 45C/h were recorded for each sample. After the fist one,
successive heating scans on the same sample always gave superimposable
thermograms. Transitions enthalpies were determined using the software
ORIGIN (MicroCal) provided with the calorimeter.
Efﬂux of liposomal and resealed erythrocyte
ghosts contents
The efflux of encapsulated solutes was assayed as described by Ellens et al.
(23), using ANTS and DPX. The probe-loaded liposomes and erythrocyte
ghosts (final lipid concentration 0.3 mM) signal was recorded as 0% efflux,
then sphingosine or ceramide was added and the ANTS and DPX efflux was
recorded for 7200 s. The reaction was performed at 37C. Changes in
fluorescence intensity were recorded in an Aminco-Bowman (Urbana, IL,)
AB-2 spectrofluorometer using 1-ml quartz cuvettes with continuous stirring.
Excitation and emission wavelengths were 355 and 520 nm, respectively. An
interference filter with a nominal cutoff value of 475 nm was placed in the
emission light path to minimize the scattered-light contribution of the vesicles
and the erythrocyte ghosts to the fluorescence signal. The percentage of efflux
is calculated after all of the fluorescent probe is released by the addition of the
nonionic Triton X-100.
Fluorescence polarization assays
The fluorescence polarization of DPH was measured at 37C, using an SLM
8100 spectrofluorometer, equipped with standard polarization accessories
and a circulating water bath. The excitation and emission wavelengths were
360 and 430 nm, respectively.
The fluorescence polarization was calculated as
P ¼ ðIvv  GIvhÞ=ðIvv1GIvhÞ;
where Ivv and Ivh represent the intensity of vertically and horizontally
polarized fluorescent light, respectively, when excitation light is vertically
polarized. The correction factor is G ¼ Ihv/Ihh. Ihv and Ihh represent the
intensity of vertically and horizontally polarized fluorescent light, respec-
tively, when excitation light is horizontally polarized. DPH was added to the
phospholipids to obtain a probe/lipid molar ratio of 1/250.
Fluorescence quenching experiments
Quenching of the DPH fluorescence by TEMPO was measured as follows.
Lipids, DPH, and (when required) TEMPO were mixed at a 300:1:1 ratio
in organic solvent, then the solvent was evaporated, and the mixture
was vacuum dried for at least 2 h in the dark. The vesicles were prepared in
20 mM PIPES, 150 mM NaCl, 1 mM EDTA, pH 7.4 as described above.
Vesicles with and without TEMPO were prepared. Fluorescence quenching
was recorded in an SLM 8100 spectrofluorometer equipped with thermo-
regulated cell holders. DPH fluorescence was excited at 360 nm; emission
was recorded at 428 nm.
RESULTS AND DISCUSSION
Permeability studies
The capacity of sphingosine to increase the permeability of
model and cell membranes was tested using the same
procedures that had revealed in the past the permeabilizing
properties of ceramides (17,20). In fact, egg ceramide was
used as a positive control in these studies. Essentially,
permeabilization was detected as the efflux of low-molecular
weight, water-soluble fluorescent molecules entrapped within
the vesicles. LUVs composed of SM/PE/Ch (2:1:1 mol ratio)
and containing ANTS/DPX were treated with either sphin-
gosine or egg ceramide dissolved in a very small volume of
ethanol, and efflux of vesicle contents was followed by an
increase in fluorescence as a function of time, according the
procedure described by Montes et al. (20). The results in Fig.
1 A show that, under our conditions, sphingosine was even
more active than ceramide in inducing release of ANTS/
DPX, whereas ethanol by itself was inactive in this respect.
The permeabilizing effect of sphingosine was dose-depen-
dent (Fig. 1 B) and reached a plateau at ;15 mol %.
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Qualitatively similar, but less important in magnitude, was
the efflux of ANTS/DPX caused by sphingosine in eryth-
rocyte ghosts in which the fluorophore/quencher couple had
been entrapped (Fig. 2).
Bilayer composition of LUV was found to be an important
factor in these experiments. The data in Fig. 3 show that,
although SM could be substituted by DPPC in the mixture
with PE and Ch without significant effects, the presence of
egg PC allowed only very low rates of release. Rapid release
was, however, observed with SM/Ch (80:20 mol ratio) mix-
tures. The relevance of these observations will become appar-
ent below.
The cause of the increased permeability
The phenomenon under consideration could be explained in
terms of i), detergent solubilization effects (24), ii), induction
of nonlamellar structures (16,20), or iii), generation of
structural defects between rigid and fluid lamellar phases
(20,25). These three hypotheses were tested for the case of
sphingosine. Detergents are soluble amphiphiles with the
capacity to form mixed micelles with membrane lipids and
proteins (26,27). The initial stages of membrane solubiliza-
tion (i.e., micellization) often include the breaking down of
the permeability barrier (28). Sphingosine is amphiphilic in
nature, and moderately soluble in water. Its critical micellar
concentration (cmc) was measured with the 1-anilinonaptha-
line-8-sulphonate method (29) under our permeability assay
conditions (buffer, pH, temperature), and a value of 18 mM
was found. Similar cmc have been observed for structurally
related molecules, such as palmitoylcarnitine (10 mM) (30)
and N-acetylsphingosine (6mM) (31). However, against what
is usually found for detergents (26,28), when permeability
was measured as a function of sphingosine concentration, no
FIGURE 1 Sphingosine- and ceramide-induced efflux of vesicular aque-
ous contents. LUVs were prepared, composed of SM/PE/Ch (2:1:1, mol
ratio) containing entrapped ANTS/DPX. Sphingosine or ceramide in ethanol
were added at time 0. (A) Time course of efflux. (:) Ethanol (control); (n)
1 10 mol % ceramide; (d) 1 10 mol % sphingosine; and (s) 1 15 mol %
sphingosine. (B) Dose-response curves. Data at time ¼ 6000 s. (:)
Ceramide; (d) sphingosine (average values 6 SD, n ¼ 3).
FIGURE 2 Sphingosine-induced release of ANTS/DPX from resealed
erythrocyte ghosts. Sphingosine in ethanol (:) or pure ethanol as a control
(s) were added at time 0. Average values 6 SD (n ¼3).
FIGURE 3 The effect of bilayer lipid composition on vesicle efflux
induced by 10 mol % sphingosine. Vesicle composition was: (¤) egg PC/
PE/Ch (2:1:1, mol ratio), (d) SM/PE/Ch (2:1:1, mol ratio), (D) DPPC/PE/
Ch (2:1:1, mol ratio), and (n) SM/Ch (80:20 mol ratio). (s) Control: effect
of ethanol alone on SM/PE/Ch vesicles.
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increase in efflux was observed at the cmc (data not shown).
Also, the fact that our systems reached an apparent equilib-
rium when ,20% of the vesicle contents had been released,
and that increasing sphingosine concentration beyond 15 mol
% had no further effect, speaks against sphingosine-induced
vesicle solubilization as the reason for the observed release.
Moreover, formation of phospholipid/sphingosine mixed mi-
celles has never been reported, to the authors’ knowledge. We
conclude that the observed increase in permeability is not due
to putative membrane solubilizing properties of sphingosine.
The transient formation of nonlamellar inverted structures
in the bilayer has been evoked as an explanation for certain
phenomena of efflux. The fact that long-chain ceramides, for
instance, facilitate the formation of the inverted hexagonal
phase (32) supports this mechanism as the basis for the
ceramide-induced increase in permeability. To test this hy-
pothesis for sphingosine, a systematic study of the thermo-
tropic phase transitions of DEPE/sphingosine mixtures at pH
7.4 was performed, using DSC. As a result, a temperature-
composition diagram (or partial phase diagram) was ob-
tained, as shown in Fig. 4. The data were very similar to the
corresponding region of the phase diagram obtained by
Lo´pez-Garcı´a et al. (7) at pH 6.0. The main conclusion that
was pertinent to our study was that, unlike ceramides, sphin-
gosine hardly displaced the boundaries of the fluid-lamellar-
inverted hexagonal phases; in other words, it did not
facilitate hexagonal phase formation. In agreement with
this, the ability of sphingosine to induce transbilayer (‘‘flip-
flop’’) lipid motion was tested according to the method of
Contreras et al. (33,34), using pyrene-PC and pyrene-PS. In
neither case was transbilayer motion detected (data not
shown). A degree of flip-flop would have been expected to
accompany the formation of nonlamellar structures. Conse-
quently, the experimental evidence did not favor the hypoth-
esis of the induction of nonlamellar structures as the basis for
the observed sphingosine-induced increase in permeability.
The lack of a major effect on the lamellar-hexagonal phase
transition was in agreement with the idea that, as discussed
above, sphingosine did not act as a detergent. Detergents us-
ually increase the lamellar-to-inverted hexagonal transition
temperature (30).
The structural defects originating at the interface between
lamellar gel and fluid domains during lateral phase separa-
tion were proposed long ago (25) to be responsible for the
increased permeability of phospholipid bilayers at the tran-
sition temperature. We have proposed a similar explanation,
at least as a possibility among others, for ceramide-induced
efflux (20,35), particularly in view of the tendency of long-
chain ceramides to separate into ceramide-rich, rigid do-
mains in the plane of the membrane. The hypothesis of the
sphingosine involvement in the rigidification of membrane
domains was tested by DSC. Different systems were tested
that had in common a relatively broad gel-fluid transition
temperature in the absence of sphingosine, namely DPPC/Ch
(80:20, mol ratio), SM/Ch (80:20, mole ratio), and SM/PE/
Ch (2:1:1, mole ratio). Note that the same mixtures were
used in permeability experiments in Figs. 1 and 3. Typical
thermograms for these mixtures are shown in Fig. 5. The
same DSC analysis was performed on samples that con-
tained, in addition, 20 mol % sphingosine. The results are
also shown in Fig. 5 and the corresponding thermodynamic
parameters are given in Table 1. In all cases, sphingosine had
the effect of increasing the midpoint transition temperature,
increasing the transition enthalpy, and narrowing the tran-
sition width. The broad and (particularly for SM-containing
mixtures) asymmetric thermograms reveal the presence of
heterogeneous microdomains in the bilayers. The interpre-
tation of these data is that, at least for certain lipid com-
positions, sphingosine mixes with the lipids in the gel phase
and gives rise to more rigid, more cooperative domains.
During this essentially isothermal, sphingosine-driven tran-
sition, more and less fluid domains will coexist. Structural
defects will appear at the interfaces between the ‘‘more fluid’’
and the ‘‘less fluid’’ domains, and permeability will be en-
hanced. Efflux appears to reach an equilibrium after ;2 h
(Figs. 1 and 3). This corresponds probably to the time re-
quired for the structural defects in the sphingosine-contain-
ing bilayer to anneal, i.e., to reach an equilibrium at constant
temperature. There are abundant examples in the literature of
molecules that produce a transient perturbation of the
membrane bilayer, so that leakage occurs for a while, then
it stops when equilibrium is restored. This behavior is found
for leakage induced by certain lipids, e.g., the above-men-
tioned ceramides (33), bacterial protein toxins, e.g., Escherichia
FIGURE 4 Temperature-composition diagram for DEPE/sphingosine in
excess water, pH 7.4. (d,s) Onset and completion temperatures of the gel-
fluid lamellar phase transition, derived from DSC thermograms. (;, =)
Onset and completion temperatures of the lamellar-to-inverted hexagonal
phase transition, also derived from DSC thermograms. Lb, lamellar gel
phase La, lamellar fluid phase HII, and inverted hexagonal phase. Average of
three measurements. The SD are about the size of the symbols.
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coli a-haemolysin (36), or even detergents at subsolubilizing
concentrations (24). In contrast, other molecules give rise to
stable pores or channels, so that leakage proceeds until the
inside and outside solute concentrations reach an equilib-
rium. This would be the case of, e.g., valinomycin with re-
spect to K1 gradients (37).
The rigidifying effect of sphingosine was further explored
using fluorescence spectroscopic techniques, namely DPH
fluorescence polarization and TEMPO-quenching of DPH
fluorescence. DPH fluorescence polarization is a well-known
method for detecting changes in bilayer order/microviscosity
(25). When DPH is incorporated into SM/PE/Ch vesicle
bilayers, and its fluorescence polarization is continuously
monitored, addition of 10 mol % sphingosine causes an im-
mediate increase in polarization (Fig. 6 A). The increase is
small in magnitude (typically of 0.01–0.02 polarization
units), but highly reproducible. This is interpreted as the
bilayer becoming more rigid as a result of sphingosine incor-
poration. Qualitatively similar results are obtained when vesi-
cles consisting of DPPC/PE/Ch (2:1:1) or of SM/Ch (80:20)
are used (data not shown). DPH fluorescence emission
intensity can be quenched by the stable radical TEMPO (38).
TEMPO partitions into fluid, but not rigid bilayers, and
quenches DPH fluorescence (38). With vesicles composed of
SM/PE/Ch (2:1:1) that contain DPH in their bilayers, addi-
tion of TEMPO causes a slow and steady quenching, i.e., a
decrease in fluorescence emission intensity (Fig. 6 B). This
slow effect of TEMPO is an indication that the bilayers al-
ready have an average low fluidity in the absence of sphin-
gosine (38). However, when sphingosine (10 mol %) is added
to the same bilayers, TEMPO is unable to quench DPH fluo-
rescence (Fig. 6 B, dotted line), confirming again the rigid-
ifying effect of sphingosine. Qualitatively similar effects are
found with DPPC/PE/Ch (2:1:1), or SM/Ch (80:20) vesicles
(results not shown).
The relationship between the rigidifying effect of sphin-
gosine and sphingosine-induced release of vesicular contents
is put forward in Fig. 7, in which the DPH polarization
change is plotted in parallel with the initial stages of efflux
for three different membrane compositions. The remarkable
parallelism of both events, recorded in different experiments,
and with different vesicle preparations (DPH-doped LUV for
polarization measurements, ANTS/DPX-loaded LUV for
efflux assays) supports the idea that both are mechanistically
linked. The reason for the delayed onset of the observed
phenomena in SM/PE/Ch bilayers (Fig. 7 C) remains to be
elucidated. Note that in the fluorescence spectroscopic ob-
servations in Figs. 6 and 7, the retrieved data correspond to
the summation of signals arising from the many individual
TABLE 1 Thermodynamic parameters for the gel-ﬂuid phase
transitions shown in Fig. 5; average values 6 SD (n = 3)
Sample
(mol ratio)
Midpoint
transition
temperature (C)
DH
(kcal/mol)
DT1/2
(C)
DPPC/Ch (80:20) 42.3 6 0.61 2.8 6 0.39 6.1 6 0.05
As above
1 20 mol % sphingosine
46.1 6 0.31 3.3 6 0.40 5.7 6 0.05
SM/Ch (80:20) 38.9 6 0.91 1.0 6 0.12 10.8 6 0.32
As above
1 20 mol % sphingosine
43.9 6 0.34 1.3 6 0.44 8.5 6 0.53
SM/PE/Ch (2:1:1) 33.0 6 1.56 1.3 6 0.12 27.3 6 0.30
As above
1 20 mol % sphingosine
37.4 6 1.60 2.3 6 0.30 23.5 6 0.88
FIGURE 5 Effect of sphingosine on the gel-fluid transition of different
lipid mixtures. (A) DPPC/Ch (80:20, mol ratio)6 20 mol % sphingosine. (B)
SM/Ch (80:20, mol ratio) 6 20 mol % sphingosine. (C) SM/PE/Ch (2:1:1,
mol ratio) 6 20 mol %sphingosine. Representative thermograms of the
second or third scans.
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probe molecules that may be distributed into different micro-
domains, each with its own physical properties. Thus our
fluorescence data point to an overall rigidification of the
bilayers caused by sphingosine, but our inference of coex-
isting domains in the LUV rely on the calorimetric, rather
than on the spectroscopic data.
It is important in this context that DPPC, but not egg PC,
could substitute SM in bilayers supporting a sphingosine-
dependent increase in permeability (Fig. 3). PC/PE/Ch mix-
tures do not give rise to visible DSC endotherms, under our
conditions. This means that no significant gel domains exist
in these mixtures. Whether the small degree of efflux in-
duced by sphingosine in PC/PE/Ch vesicles (Fig. 3) is due to
formation of (low-cooperativity) domains, or to other causes,
remains to be explored.
The tendency of sphingosine to mix with lipids in the gel
state has been observed for similar molecules, such as satu-
rated fatty acids (39,40). Sphingosine had been found to ri-
gidify PC and PS membranes (7,8,11,13), and, very recently,
also sphingomyelin-rich domains (41). What a well-known
detergent such as Triton X-100 has in common with
sphingosine are that it mixes well with lipids in the gel state
(42) and that it helps create ordered domains in membranes
(43), although, as mentioned above, sphingosine cannot solu-
bilize membrane bilayers. Saily et al. (44) performed a Lang-
muir film balance study in which sphingosine was seen to
increase lateral packing of PC monolayers. In our systems,
all of which contain cholesterol, sphingosine may exert its
FIGURE 6 Rigidifying effect of sphingosine on vesicle membranes. (A)
DPH fluorescence polarization. Vesicles composed of SM/PE/Ch (2:1:1,
mol ratio), containing DPH at a 1:250 DPH/lipid mol ratio, were incubated
while DPH fluorescence polarization was continuously recorded. Sphingo-
sine (10 mol %) was added at the point indicated by the arrow (time 0). (B)
TEMPO quenching of DPH fluorescence emission. Vesicles composed of
SM/PE/Ch (2:1:1, mol ratio), containing DPH as above, were incubated
while DPH fluorescence emission intensity was recorded. The change in
fluorescence is plotted as F/Fo (fluorescence measured in the presence/in the
absence of TEMPO). (Solid line) Experiment in the absence of sphingosine.
(Dotted line) Experiment in the presence of 10 mol % sphingosine.
FIGURE 7 Parallel behavior of sphingosine-induced rigidification and
vesicle efflux. (Solid line) DPH fluorescence polarization. (d) Vesicle
efflux. The dotted lines are only meant to guide the eye. Vesicle composition
was as follows: (A) DPPC/PE/Ch (2:1:1, mol ratio). (B) SM/Ch (80:20,
mol ratio). (C) SM/PE/Ch (2:1:1, mol ratio).
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gel-stabilizing effect by counteracting the propensity of cho-
lesterol to increase the ‘‘negative curvature’’ (45) of the
bilayer. Sphingosine and cholesterol have, in fact, opposed
molecular geometries (46) that give them a tendency to favor
positive and negative curvatures respectively. The coexis-
tence of both lipids at roughly similar mole ratios may com-
pensate both effects. Siskind et al. (16) noted that ceramides
and sphingosine increased membrane permeability through
different mechanisms. Although the electrophysiological
techniques used by these authors provide data at a very dif-
ferent scale (in time and space) from ours, we concur in
suggesting that nonlamellar phase formation is probably an
important factor in ceramide-induced efflux of vesicle con-
tents, whereas it is probably irrelevant for sphingosine. Con-
versely, the reinforcement of rigid domains appears to be the
key phenomenon for sphingosine action. The current ac-
ceptance of rigid, or at least liquid-ordered, domains in the
plasma membrane of cells makes such membranes a target
for sphingosine-induced permeabilization, as shown in Fig. 2
for the simple case of the erythrocyte membrane.
Sphingosine is known to have apoptotic and antiprolifer-
ative effects on cells (see review in Birbes et al. (47)). These
effects are the overall result of a large number of direct and
indirect inhibitory and stimulatory actions on individual en-
zymes, e.g., inhibition of conventional and novel isoforms of
protein kinase C (48), stimulation of diacylglycerol kinase
(49), or stimulation of phospholipase C (50). The observa-
tions in our study open a number of novel possibilities for ex-
plaining sphingosine effects at a molecular level. In general,
the above enzymes are not known to possess sphingosine-
binding sites, but most of them are known to be membrane-
bound at some stage in the catalytic cycle (47,50), thus
sphingosine effects on fluidity could modify the enzyme
activities. In addition, sphingosine-induced permeabilization
of the plasma membrane should lead to (localized and
transient) alterations of the ion gradients, e.g., Ca21 entrance
into the cytoplasm. These changes in ion concentrations could
in turn modify enzyme activities, since many protein kinases
C, diacylglycerol kinases, and phospholipases C, among other
enzymes, are dependent on Ca21 for catalysis (51–53). Thus
our results may be used as a guide in future studies at the
cellular level.
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